학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 76건 | 목록 1~20
Academic Journal
Uribe-Herranz M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Oliver-Caldés A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Martínez-Micaelo N; Biosfer Teslab, Reus, Spain.; Español-Rego M; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Val-Casals M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Gyala Therapeutics S.L., Barcelona, Spain.; Martínez-Soler R; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Rubio-Garcia E; Department of Clinical Microbiology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic of Barcelona, Barcelona, Spain.; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Molecular Core Facility, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic of Barcelona, Barcelona, Spain.; Departament of Fonaments Clínics, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Brunello V; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Mihelic EZ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Klein-González N; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Gyala Therapeutics S.L., Barcelona, Spain.; Benítez-Ribas D; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Amigó N; Biosfer Teslab, Reus, Spain.; Department of Basic Medical Sciences, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Vergara A; Department of Clinical Microbiology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic of Barcelona, Barcelona, Spain.; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Departament of Fonaments Clínics, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.; Ortiz-Maldonado V; Hematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Rodríguez-Lobato LG; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Delgado J; Hematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Ortiz de Landazuri I; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; González-Calle V; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain.; Cabañas V; Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, University of Murcia, Murcia, Spain.; Martin-Antonio B; Departamento de Desarrollo de Medicamentos de Terapias Avanzadas, Instituto de Salud Carlos III, Madrid, Spain.; Pérez-Amill L; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Gyala Therapeutics S.L., Barcelona, Spain.; Reguera-Ortega JL; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Sevilla, Sevilla, Spain.; Rodríguez-Otero P; Clínica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369, Pamplona, Spain.; Paiva B; Clínica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369, Pamplona, Spain.; Martínez-López J; Hospital Universitario 12 de Octubre, Complutense University, i+12, CNIO, Madrid, Spain.; Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain.; Pascal M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Urbano-Ispizua Á; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; González-Navarro EA; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Fernández de Larrea C; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Juan M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Clinical Immunology Unit Hospital Sant Joan de Déu-Hospital Clínic de Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Academic Journal
Bartoló-Ibars A; Joint Platform of Immunotherapy Hospital Sant Joan de Déu (HSJD)-Hospital Clínic of Barcelona (HCB), Barcelona, Spain.; Fundació de Recerca Clínic Barcelona - IDIBAPS, Barcelona, Spain.; Aran A; Joint Platform of Immunotherapy Hospital Sant Joan de Déu (HSJD)-Hospital Clínic of Barcelona (HCB), Barcelona, Spain.; Fundació de Recerca Clínic Barcelona - IDIBAPS, Barcelona, Spain.; Johansson AM; Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.; Ortiz-Maldonado V; Fundació de Recerca Clínic Barcelona - IDIBAPS, Barcelona, Spain.; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Klein-González N; Joint Platform of Immunotherapy Hospital Sant Joan de Déu (HSJD)-Hospital Clínic of Barcelona (HCB), Barcelona, Spain.; Fundació de Recerca Clínic Barcelona - IDIBAPS, Barcelona, Spain.; Alonso-Saladrigues A; Leukemia and Lymphoma Department, Pediatric Cancer Center Barcelona HSJD, Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; James E; Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.; Urbano-Ispizua A; Fundació de Recerca Clínic Barcelona - IDIBAPS, Barcelona, Spain.; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Rives S; Leukemia and Lymphoma Department, Sant Joan de Deu Hospital, Barcelona, Spain.; Sant Joan de Deu Research Institute, Barcelona, Spain.; Delgado J; Fundació de Recerca Clínic Barcelona - IDIBAPS, Barcelona, Spain.; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; González-Navarro EA; Joint Platform of Immunotherapy Hospital Sant Joan de Déu (HSJD)-Hospital Clínic of Barcelona (HCB), Barcelona, Spain eagonzal@clinic.cat mjuan@clinic.cat.; Fundació de Recerca Clínic Barcelona - IDIBAPS, Barcelona, Spain.; Department of Immunology, HCB, Barcelona, Spain.; Kwok WW; Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.; Juan M; Joint Platform of Immunotherapy Hospital Sant Joan de Déu (HSJD)-Hospital Clínic of Barcelona (HCB), Barcelona, Spain eagonzal@clinic.cat mjuan@clinic.cat.; Fundació de Recerca Clínic Barcelona - IDIBAPS, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Department of Immunology, HCB, Barcelona, Spain.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Pérez-Amill L; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Gyala Therapeutics S.L, Barcelona, Spain.; Department of Immunology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Bataller À; Department of Haematology, Institut Clínic de Malalties Hematològiques i Oncològiques (ICHMO), Hospital Clínic de Barcelona, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Delgado J; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Haematology, Institut Clínic de Malalties Hematològiques i Oncològiques (ICHMO), Hospital Clínic de Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Esteve J; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Haematology, Institut Clínic de Malalties Hematològiques i Oncològiques (ICHMO), Hospital Clínic de Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Juan M; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Department of Immunology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Hospital Sant Joan de Déu, Universidad de Barcelona, Barcelona, Spain.; Klein-González N; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Gyala Therapeutics S.L, Barcelona, Spain.; Department of Immunology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Klein-Gonzalez, N.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어